Opioid-Induced Constipation Market by Route of Administration, Class of Drugs, and Geography - Forecast and Analysis 2020-2024

Executive Summary

Market Landscape

• Market ecosystem
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2019
• Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

• Five forces summary
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by route of administration

• Market segments
• Comparison by route of administration
• Oral - Market size and forecast 2019-2024
• Parenteral - Market size and forecast 2019-2024
• Market opportunity by route of administration

Market Segmentation by class of drugs

• Peripherally acting mu-opioid receptor antagonists
• Locally acting chloride channel activator
• Other drugs

Customer landscape

• Overview

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• Asia - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity by geography
• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Overview
• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• AstraZeneca Plc
• Bausch Health Companies Inc.
• Daiichi Sankyo Co. Ltd.
• Ironwood Pharmaceuticals Inc.
• Mallinckrodt Plc
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• SHIONOGI Co. Ltd.
• Takeda Pharmaceutical Co. Ltd.

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations